| Net Cash Provided by (Used in) Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
4.08M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
0 |
USD |
|
Q1 2023 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
115K |
USD |
+10.6% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
115K |
USD |
+10.6% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
548K |
USD |
+10.6% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
534K |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
11.4K |
USD |
+173% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |